121 results on '"B. Noris Chiorda"'
Search Results
2. Assessing the impact of salvage radiation therapy field after radical prostatectomy: A long-term analysis from a large multi-institutional series
3. Assessing the optimal timing of salvage radiation therapy administration after radical prostatectomy: A stage-specific analysis from a large multi-institutional series
4. A predictive model to personalize follow up schedules for patients in active surveillance
5. PO-1595 Automated stability study on mpMRI prostate radiomics features to variations in segmentation
6. PD-0415 Pelvic RT in prostate cancer: late intestinal toxicity is modulated by severity of acute symptoms
7. Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: the key role of PSA kinetics
8. PO-1342 Trends and predictors of worsening at RT end of anxiety and depression during RT for prostate cancer
9. PD-0769 Patient-reported acute intestinal toxicity and impact on patient QoL after WPRT for prostate cancer
10. PH-0660 Independent role of dose-escalation and prophylactic WPRT in salvage RT after radical prostatectomy
11. PD-0161 Single-patient microbiota & inflammation profiles modulate dose-response curves for acute toxicity
12. PD-0414 Trend over time of patient-reported QoL domains after pelvic nodal irradiation for prostate cancer
13. High-Performance Cellular Radiosensitivity Assay Combined to a Polygenic Score to Predict Late Post Radiotherapy Overreaction in Cancer Prostate Patients: A Proof of Concept
14. PD34-02 THE KEY ROLE OF PSA DOUBLING TIME IN PATIENTS TREATED WITH SALVAGE RADIATION THERAPY AFTER RADICAL PROSTATECTOMY: IMPLICATIONS FOR THE EXTENT OF RADIATION AND THE CONCOMITANT USE OF HORMONAL THERAPY
15. PSA doubling time as predictor of relapse after early salvage radiation therapy: When should imaging be used to select patients who might not benefit from early local treatments?
16. Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: The key role of PSA kinetics
17. What is the optimal duration of hormonal treatment during salvage radiotherapy in men with pN1 prostate cancer? Results form a large multi-institutional series
18. Assessing the impact of salvage radiation therapy field after radical prostatectomy: a long-term analysis from a large multi-institutional series
19. Assessing the optimal timing of salvage radiation therapy administration after radical prostatectomy: A stage-specific analysis from a large multi-institutional series
20. PO-1345 Symptoms affecting Emotional, Systemic and Social Domains 2 years after RT for prostate cancer
21. PO-1354 Time Dependence of PSADT prognostic threshold in men treated with post-prostatectomy salvage RT
22. PD-0767 Predictors of urinary incontinence 2 years after RT with different intents for prostate cancer
23. PO-1363 Prediction of urinary toxicity after prostate cancer RT: long term evaluation
24. PD-0782 Predicting bRFS after salvage post-prostatectomy RT with a 'one-size-fits-all' TCP-based formula
25. PH-0108 New dose-volume constraints for patient-reported acute bowel toxicity symptoms in whole pelvis IMRT
26. Independent role of dose-escalation and prophylactic lymph-nodal irradiation in salvage radiotherapy after prostatectomy. A retrospective, multi-institute analysis on 725 men treated with high-dose radiotherapy and eight years follow-up
27. Comparison of salvage radiation therapy delivered for PSA persistence versus PSA relapse after radical prostatectomy: How is the outcome changing?
28. There is no way to compensate a non-timely use of early salvage radiation therapy in men with recurrent Prostate Cancer after Radical Prostatectomy. A retrospective, multi-centre analyses on oncological and toxicity outcomes
29. Which patients should be still considered for late salvage radiotherapy for rising or persistently elevated PSA after radical prostatectomy: Results from a large multi-institutional study
30. Assessing the effect of concomitant hormonal therapy on severe toxicity in patients treatedwith post-prostatectomy radiation therapy: results from a large, multi-institutional study
31. The key role of PSA doubling time in patients treatedwith salvage radiation therapy after radical prostatectomy: implications for the extent of radiation and the concomitant use of hormonal therapy
32. PH-0119: Modulations of gut microbiota following radiotherapy for prostate cancer
33. Changing patterns and predictors of salvage radiation therapy use over time in patients treated for post-prostatectomy biochemical recurrence: a trend analysis over a 20-year period from a multi institutional series
34. Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I–II Study
35. Cure without toxicity: development of a novel model predicting trifecta outcomes after salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
36. There is no way to compensate for a non-timely use of salvage radiation therapy in men with recurrent prostate cancer after radical prostatectomy
37. OC-0616 Introducing information on gut microbiota into toxicity modeling: preliminary results from a trial
38. PO-0837 Dose-effect relationship for early late incontinence after IMRT in post-prostatectomy patients
39. PO-0850 Comparison of self-reported acute urinary incontinence in pts treated with adjuvant or salvage IMRT
40. PO-0851 Quality of life after whole pelvis RT for prostate cancer: results from a prospective study
41. Dose-effect relationship for 1-year incontinence after post-prostatectomy intensity-modulated radiotherapy (MRT)
42. What is the best definition of biochemical response to salvage radiation therapy in prostate cancer patients treated for PSA rising after radical prostatectomy? Results from a multi-institutional series
43. Do number of biopsies and PSA doubling time at 3 and 5 years in active surveillance protocols associate with upgrading reclassification?
44. Assessing the impact and predictors of other-cause mortality in patients treated with post-prostatectomy salvage radiation therapy in order to avoid possible overtreatment: Results from a large, multi-institutional study
45. Comparison of self-reported acute urinary incontinence in patients treated with adjuvant or salvage post-prostatectomy intensity modulated-radiotherapy (IMRT)
46. Clinical Results for an Active Surveillance Cohort with Localized Prostate Cancer Receiving RT after Exiting Active Surveillance
47. Evaluation of Inflammatory Marker Levels in Patients Treated with Radiation Therapy for Prostate Cancer
48. PV-0627: Hematologic toxicity after whole-pelvis irradiation: results of a longitudinal observational study
49. PO-0820: The bowel syndrome after whole pelvis RT for prostate cancer: acute symptoms and quality of life
50. PO-0826: Factors affecting self-reported, long-term (1-2 yrs) urinary incontinence from post-prostatectomy RT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.